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A rapid progression from conventional open surgery to minimally invasive approaches in the surgical management of colorectal
cancer has occurred over the last 2 decades. Initial concerns that this new approach was oncologically inferior to open surgery
were ultimately refuted when several prospective randomized trials concluded that laparoscopic colectomy could achieve similar
oncologic outcomes to open surgery. On the contrary, level 1 data has not yet matured regarding the oncologic safety of minimally
invasive approaches for rectal cancer. We review the published literature pertaining to the evolution of minimally invasive
techniques used to treat colorectal cancer surgery, including barriers to adoption, and the prospects for future advances related to
innovative techniques.
1.Introduction
Since the introduction of laparoscopic surgery, minimally
invasive techniques have been broadly applied across multi-
plespecialtiesforbothbenignandmalignantconditions.The
adoption of laparoscopic cholecystectomy by general sur-
geons following its inception in 1987 marked an important
transition away from more invasive open techniques [1]. In
1991, Jacobs et al. reported the ﬁrst laparoscopic colectomy,
and the enthusiasm for laparoscopic colectomy grew when
recovery beneﬁts for patients became more apparent [2].
Though many surgeons soon became comfortable with lap-
aroscopic colectomy for benign disease, the application of
minimally invasive surgery (MIS) to malignant colorectal
disease was slow due to oncologic concerns [3]. With
time,numerousrandomizedcontrolledtrialscomparinglap-
aroscopic to open surgery for colon cancer were published,
clearlydemonstratingthatinexperiencedhands,appropriate
oncologic resections can be performed and produce results
equivalent to the open techniques [4–7]. In contrast, the
outcomes of MIS for rectal cancer have not yet been de-
ﬁnitively studied, but large randomized, multicenter trials
are underway. Because rectal cancer surgery demands more
technical expertise (total mesorectal excision, low pelvic
anastomosis) than colectomy, many have concerns that on-
cologic principles may be compromised when rectal cancer
is treated laparoscopically, leading to worse oncologic out-
comes.
In addition to oncologic concerns, the widespread appli-
cation of laparoscopic techniques to colorectal cancer was
alsolimitedbythesubstantiallearningcurveencounteredfor
many surgeons, especially those not trained in MIS. Hand-
assisted techniques introduced in the early 1990s made an
attempt to overcome some of these limitations, providing
an overlap between open and laparoscopic techniques and
thus facilitating the transition from open to MIS for many
surgeons [8].
The acceptanceof minimally invasive procedures by both
patients and surgeons has led many surgical innovators and
industry to develop new technology with the goal of even
less invasive approaches. The advent of the single-incision
laparoscopic surgery (SILS) devices has allowed fewer inci-
sions [9]. Robotic techniques popularized in other speciali-
t i e s ,s u c ha su r o l o g y ,h a v eb e e na p p l i e dt os u r g e r yf o rr e c t a l
cancer to overcome the limitations of conventional lap-
aroscopy in the conﬁned working space of the pelvis [10,
11]. The clinical application of natural oriﬁce transluminal
endoscopicsurgery(NOTES)tocolorectaldiseasehasnotyet2 International Journal of Surgical Oncology
fully transpired, though there have been major advances as
instrumentation improves and transitional techniques allow
natural oriﬁce specimen extraction following laparoscopic
colectomy [12–15].
The aim of this paper is to review the published literature
regarding the evolution of MIS for colorectal cancer includ-
ing thebarrierstoadoption, currentstatus,andprospectsfor
future advances related to innovative techniques.
2. MISforColonandRectalCancer:WhereHave
We Been?
After the initial description in 1991, several reports of MIS
for colorectal cancer were described. Signiﬁcant concerns re-
garding this approach surfaced when minimally invasive
techniquesappliedtocolorectalmalignancyleadtoincreased
surgicalcomplicationsandworsecanceroutcomescompared
to conventional open approaches. An early report, using
minimally invasive techniques for benign colorectal disease,
showed a signiﬁcantly high rate of serious complications
(18%), including inadvertent enterotomies, intraoperative
hemorrhage, anastomotic leaks, and pelvic abscesses [16].
When MIS was used to treat colorectal cancer, several papers
noted early wound or trocar site recurrences, including one
case series documenting a 21% rate [3]. With a less than 1
percent wound implantation rate for open surgery, serious
concerns were raised as to the possibility that poor oncologic
results were due to a combination of poor technique and ab-
normal distribution of malignant cells secondary to pneu-
moperitoneum [17]. Further concerns that laparoscopic
techniquesmaybeproblematictocancerpatientsarosewhen
some studies demonstrated statistically signiﬁcant worse
cancer-speciﬁc survival in patients who had conversion
from laparoscopic to open surgery [18, 19]. Moloo et al.
described decreased survival at 2 years of 76% from 87% for
allstages(P = 0.02)ofcolorectalcancercollectedfromapro-
spectivedatabaseof377consecutivelaparoscopicpatients.In
the same cohort, at 5 year followup, there was a trend toward
decreased overall survival in converted patients (61.9%
versus 69.7%, P = 0.077). Chan et al. showed an increased
localrecurrencerateat3yearfollowupof9.8%inthelaparo-
scopically converted group as compared to 2.8% in open pa-
tients (P = 0.03).
The oncological concerns raised in early reports pro-
vided a compelling argument to study the question of on-
cologic equivalence between the open and laparoscopic ap-
proach to colorectal cancer in a controlled fashion. In the
early1990s,severalmulticenterprospectiverandomizedcon-
trolled trials comparing laparoscopic and open surgery for
colorectal cancer were initiated. Ultimately, seven large-
scale trials compared laparoscopic and open colectomy for
colon carcinoma and examined short-term and long-term
outcomes. These trials included the Clinical Outcomes of
Surgical Therapies (COST) trial funded by the National
Cancer Institute in the United States, the Conventional
versus Laparoscopic-Assisted Surgery in Colorectal Cancer
(CLASICC) trial in the United Kingdom, the Colon Cancer
Laparoscopic or Open Resection (COLOR), a multicenter
European trial, the Barcelona trial, and several others [20–
26]. The main focus of these trials was oncologic outcomes,
but short-term outcomes, quality of life, and safety were also
evaluated. The CLASICC trial was the only large trial that
also evaluated MIS in rectal cancer.
3. MIS for Colon Cancer: Where Are We Now?
Though modest in early studies, the short-term patient-
related advantages of laparoscopic surgery have now been
conﬁrmed and are signiﬁcant over the open approach.
The Minimally Invasive Colorectal Resection Outcomes
(MICRO) review identiﬁed 22 randomized controlled trials
and 66 cohort series for benign and malignant colorectal
disease [27]. Laparoscopic colectomy results in signiﬁcantly
lower pain scores and analgesia requirements, estimated
blood loss, return of bowel function, and length of stay.
Numerous other trials, including the COST, COLOR, and
CLASICC trials, examining short-term outcomes following
laparoscopic colectomy for colorectal cancer have conﬁrmed
theseﬁndings[20–26,28].Severalstudieshavealsoidentiﬁed
a decreased rate of postoperative morbidity including fewer
woundinfections[21,23,27,29];thiswasrecentlyreinforced
by a large trial from the National Surgical Quality Improve-
ment Program (NSQIP) database of over 10,000 patients
identifyingdecreasedincidenceofwoundinfectionfollowing
laparoscopic colectomy (9.5% versus 16.1%, P<0.001) [30].
Quality of life has been assessed in several trials and results
varied from no diﬀerence to favoring improved quality of life
in laparoscopic colectomy [31].
The initially cited oncologic concerns of laparoscopic
colectomyforcolorectalcancerwerelaterdispelledwhensur-
geons trained in appropriate laparoscopic oncologic resec-
tion performed operations in the trial setting. Major trials,
includingtheCOST,CLASICC,andCOLORtrials,examined
tumorspecimensandreported long-termdataonrecurrence
and survival. The surgical specimens were evaluated, and
parameters such as lymph node yield, circumferential radial
margins, and longitudinal margins were quantiﬁed. No
trial identiﬁed statistically signiﬁcant diﬀerences in lymph
node yield [20–26] or resection margins [20, 22, 26]. This
initial evidence allayed some concerns regarding oncologic
resections, but the long-term measures for recurrence and
survival were still unknown. Trial data matured, and more
evidence accumulated conﬁrming similar recurrence pat-
terns and rates between laparoscopic and open colectomy.
Local recurrence, distant recurrence, and wound or port site
metastases were the same between groups [4, 5, 7, 24, 32–
34]. Disease-free and overall survival in long-term followup
(up to 7 years) is equivalent [4, 5, 7, 32–34]. The concern
thatconversionfromlaparoscopictoopensurgeryinpatients
withcoloncancermayleadtoworseoncologicoutcomeswas
not seen when 5-year COST trial data showed no statistical
diﬀerence in these two groups [5] (see Table 1).
Despite evidence demonstrating improved short-term
outcomes of laparoscopic colectomy and oncologic equiv-
alence, widespread implementation of this technique was
slow. The lack of formalized training, outside single-dayInternational Journal of Surgical Oncology 3
Table 1: Short-term and long-term outcomes of large-scale randomized controlled trials for laparoscopic colectomy compared to open
colectomy for colon cancer.
COST CLASICC COLOR Barcelona Braga Milsom Liang
[5, 20, 28][ 6, 22, 32][ 4, 26][ 7, 23][ 21, 33][ 25][ 24]
Return of bowel function = ↓↓↓ ↓ ↓
Pain score ↓↓
Narcotic use ↓↓ ↓
Length of stay ↓↓ ↓ ↓ ↓ =
OR time ↑↑ ↑ ↑ ↑ ↑ ↑
EBL ↓↓↓ = ↓
LN yield == = = = = =
Circumferential margin + ==
Postoperative morbidity == = ↓↓ ==
Postoperative mortality == = = ↓ =
Quality of life == ↑
Overall survival == = = =
Disease-free survival == = = =
Local recurrence == = =
Distant recurrence == = = =
Wound/port recurrence == = = = = =
OR: operating room; EBL: estimated blood loss; LN: lymph node. Each outcome recorded is compared to open controls. ↑ or ↓ represents a statistically
signiﬁcant diﬀerence related to the outcome; otherwise, = represents no statistical diﬀerence.
laparoscopic training courses, and the signiﬁcant learning
curve for straight laparoscopic techniques likely represented
signiﬁcant barriers to adoption. As hand-assisted laparo-
scopicsurgerygrewinpopularity,amorewidespreadadapta-
tion with fewer conversions to open surgery occurred in part
due to a shorter learning curve with this technique. Three
randomized controlled trials have been performed to com-
pare a hand-assisted technique to a laparoscopic technique
including patients with both benign and malignant disease,
all demonstrating decreased rates of conversion to open
surgery [35–37]. A recent meta-analysiscompiling 13 studies
demonstrated decreased operative times and decreased open
conversion rates with an hand-assisted approach [38]. There
were no diﬀerences in short-term clinical outcomes or
oncologicresectionresults.ArecentstudybytheMayoClinic
prospectively analyzed the use of hand-assisted surgery in a
minimally invasive colorectal practice and found that when
applied to a center performing large volumes of laparoscop-
ic surgery, hand-assisted techniques were responsible for
more complex procedures to be done laparoscopically [39].
This technique is a minimally invasive approach that has
been helpful for surgeons to transition from open to
laparoscopic colectomy, especially if they have had little pre-
vious laparoscopic experience. Moreover, this technique has
allowed a MIS approach in patients otherwise not previously
considered candidates (obese, adhesions).
As surgeon experience increased and as more studies
demonstrated that laparoscopic colectomy for benign and
malignant disease is an acceptable alternative to open
surgery, the overall ratio of laparoscopic to open colectomies
in the United States has increased. A recent analysis from
2000 through 2004 demonstrated an increasing incidence
of laparoscopic colectomy from 3% to 6.5% nationally with
increased rates of laparoscopic approaches in urban centers
and teaching hospitals [40]. A separate study and database
of patients from 2004 through 2006 identiﬁed over 32,000
patients, of which 34% underwent laparoscopic colectomy
[41]. This trend toward increased laparoscopy has also been
inﬂuenced by public knowledge and patient demand for this
approach, as well as improved and formalized laparoscopic
training in residency programs.
4. MIS for Rectal Cancer: Where Are We Now?
Thebeneﬁtsandoncologicresultsoflaparoscopictechniques
in rectal cancer surgery have not yet been deﬁnitively
established. Several trials show similar outcomes as laparo-
scopic colectomy for colon cancer; however, level 1 data is
lacking. Several multicenter randomized prospective trials
are ongoing, and data will mature in the near future:
American College of Surgeons Oncology Group (ACOSOG)
Z6051 in the United States, the COLOR II trial of Europe,
Canada, and Korea, and the Japan Clinical Oncology Group
(JCOG) 0404 trial [42].
Despite limited randomized multicenter trials, several
single institution comparative studies have shown promising
results using MIS for rectal cancer. Leung et al. compared
laparoscopic to open resection of rectosigmoid carcinoma
in over 400 patients [43]. Laparoscopic resection demon-
strated improved short-term outcomes, longer operative
times, decreased estimated blood loss, equivalent morbidity
and mortality, and equivalent long-term results of overall
survival, disease-free survival, and local and distant re-
currence. In a subgroup analysis of upper rectal cancer
lesions undergoing anterior resection, these ﬁndings were4 International Journal of Surgical Oncology
reiterated [44]. For abdominoperineal resection, Ng exam-
ined 99 patients and again demonstrated improved short-
term outcomes, longer operative times, equivalent morbidity
and mortality, and equivalent long-term results of overall
survival, disease-free survival, and local recurrence [45].
Each study demonstrated similar oncologic resection results
including equivalent lymph node yield and resection mar-
gins. Rullier evaluated his single center data for laparoscopic
rectal cancer speciﬁcally examining long-term outcomes and
resection margins for completeness of a total mesorectal
excision (TME). In the largest series of 471 patients, 92% of
laparoscopic excisions versus 94.8% of open excisions had
an R0 resection (P = 0.22), with no diﬀerence of local
recurrence (3.9% versus 5.5%, P = 0.37) and disease-free
survival (82% versus 79%, P = 0.52) at 5 years [46]. Upon
examiningmidtolowrectalcancerspecimensofT1/T2orT3
tumors (17% versus 83%) following laparoscopic excision,
88% had an intact TME with R0 resection in 93% of cases
[47]. Only one randomized trial from Brazil of 28 patients
demonstrated decreased lymph node yield [48]. A meta-
analysis of short-term outcomes conﬁrmed the ﬁndings of
faster return of bowel function, decreased analgesia use,
and decreased length of stay in laparoscopic patients [49].
Operative times were longer with similar lymph node yield
and rates of positive circumferential radial margins.
Theonlymulticenterrandomizedtrialtodatewithonco-
logic outcome data examining laparoscopic rectal cancer is
the CLASICC trial, which included both colon and rectal
adenocarcinoma patients [6, 22, 32]. A subgroup analysis
of the laparoscopic rectal dissection patients demonstrated
a concerning trend toward increased positive circumferential
radial margins (12% versus 6%, P = 0.19) following anterior
resection with equivalent distal margins and lymph node
yield for all rectal cancers [6]. There was no diﬀerence in the
overall survival, disease-free survival, or local recurrence at 3
years (see Table 2).
Pelvic dissection for rectal carcinoma is technically chal-
lenging due to limited visual exposure, operating within a
narrow conﬁned space, and the possibility of local invasion
to surrounding structures. Laparoscopic dissection may
overcome some of these diﬃculties by oﬀering improved
visual angles and magniﬁcation of the pelvis. Unfortunately,
several technical challenges must be overcome for the success
of laparoscopic rectal dissection. Adequate rectosigmoid re-
traction must be achieved by the operative assistant in
order to provide exposure and tissue tension for dissection.
Further, the narrow conﬁnes of the pelvis limit the mobility
ofstandardlaparoscopicinstruments.Ifananteriorresection
is performed, the current laparoscopic stapling devices are
diﬃcult to maneuver into a narrow pelvis and position for a
perpendicular staple line, leading to suboptimal distal rectal
transection from multiple staple ﬁrings.
Robotic surgical platforms have been proposed as a way
to overcome the limitations described above for laparoscopic
rectalcancersurgery.Althoughtherearenorandomizedcon-
trolledtrialsforroboticTMEforrectalcancer,severalstudies
demonstrate similar operative duration, intraoperative and
postoperative complication rates, and short-term outcomes
when compared to laparoscopic controls [10, 11, 50–54].
Robotic TME has similar distal and circumferential radial
margins when compared to laparoscopic controls, therefore
demonstrating feasibility for this technique [10, 50–54].
Some reports have demonstrated similar overall survival,
disease-free survival, and local recurrence at 3 years when
compared to laparoscopic approaches [6, 10, 50]. Despite
similar operative times, there is a trend toward increased cost
with robotic approaches [51]. More rigorous studies are still
needed to determine the utility and eﬃcacy of robotic sur-
gery for rectal cancer.
5. MIS for Colorectal Cancer: Where Are
We Going?
Thetransition frominvasive open surgeryto laparoscopyhas
triggered a surge of innovative techniques and technologic
advances for application to many speciﬁc surgical proce-
dures. These new techniques and technologic advances at-
tempt to overcome some of the limitations of standard lap-
aroscopy, decrease patient morbidity, and improve cosmesis.
For example, single incision laparoscopic surgery (SILS)
limits the number of port sites needed and therefore de-
creases tissue trauma and improves cosmesis. Natural ori-
ﬁce transluminal endoscopic surgery (NOTES) oﬀers an
alternative specimen extraction site in order to eliminate
abdominal wall incisions necessary for specimen extraction.
Innovativedevicessuchasnewportdesigns,instrumentation
with increased mobility, and robotics allow the transition
toward newer less invasive surgical techniques. Clinical trials
evaluating each technique are necessary to ensure continued
patient safety and oncologically appropriate surgery.
SILS (also referred to as SPA (single-port access) or SPLS
(single-port laparoscopic surgery)) is a new addition to the
colorectal surgeon’s armamentarium. The ﬁrst description of
the application of SILS to general surgery was a cholecys-
tectomy in 1997 [55]. Since its inception, SILS has also
been applied to appendectomy, splenectomy, herniorrhaphy,
tubal ligation, and more. To date, there have been only a
handful of case reports of SILS application to colorectal sur-
gery;however,initialdescriptionsappearpromising.In2008,
2 groups reported their initial experience with SILS right
colectomy [56, 57]. Since these reports, two small series have
now published outcomes for SILS hemicolectomy in benign
and malignant disease [58, 59]. Case-matched analysis com-
paringSILSandlaparoscopiccolectomyhaverevealedsimilar
operative time, length of stay, lymph node yield, and com-
plication rate [58].
As new limited access techniques evolve, we must be
cautious that limited access to the abdomen does not result
in risky or inadequate surgery. Patient selection and speciﬁc
instrumentation are also essential to successful SILS colec-
tomy. Given the learning curve required to operate under
mobility constraints, ideal candidates for SILS colectomy
h a v ef e wo rn op r i o rs u r g e r i e sa n daB M I<30. Essential
instrumentation includes an elongated laparoscope such as
a bariatric length laparoscope or a ﬂexible tip laparoscope in
order to move the camera away from the operating handsInternational Journal of Surgical Oncology 5
Table 2:Short-termandlong-termoutcomesofrandomizedcontrolledtrialsforlaparoscopicrectalsurgerycomparedtoopenrectalsurgery
for rectal cancer.
Araujo [48]C L A S I C C [ 6, 32]N g [ 45]N g [ 44] Leung [43]
Return of bowel function ↓↓ ↓
Pain score = ↓
Narcotic use ↓↓ ↓
Length of stay == ↓↓
OR time ↓↑ ↑ ↑
EBL == = ↓
LN yield ↓ == =
Circumferential margin + == =
Postoperative morbidity == = =
Postoperative mortality == =
Overall survival == = =
D i s e a s ef r e es u r v i v a l == = =
Local recurrence == = = =
Distant recurrence ==
OR: operating room; EBL: estimated blood loss; LN: lymph node. Each outcome recorded is compared to open controls. ↑ or ↓ represents a statistically
signiﬁcant diﬀerence related to the outcome; otherwise, = represents no statistical diﬀerence.
and, therefore, prevent crowding and allow working instru-
ment triangulation. SILS often requires the surgeon’s hands
to cross each other during dissection creating internal and
external conﬂicts; this requires adaptation and skill to adopt.
Robotics may overcome this technical limitation of single-
port surgery: the arms of the robot can be positioned at
varying angles and depths, and the robot allows the surgeon
to choose the instrument to be controlled by each hand,
regardless of the robotic arm that holds the instrument.
Robotics in SILS has been successfully performed in an
animal model [60].
A transition to NOTES surgery has been increasingly
cited in the past year with a partial colectomy performed
laparoscopically and the specimen extracted via a natural
oriﬁce. This is a technique that limits abdominal trauma
to small trocar port sites only. Several recent articles have
described specimen extraction transvaginally or transanally
with success [12–15]. Franklin et al. described transanal
extraction following left hemicolectomy for stage III colorec-
tal carcinoma with good oncologic results [61]. Interestingly,
as we reﬂect on the history of laparoscopic colorectal surgery
to the present, it is interesting to note that Jacobs et al.
actually utilized transrectal extraction for some of the ﬁrst
laparoscopiccolectomysurgeriesperformedin1991[2].Bar-
rierstotransanalortransrectalextractionincludeanalsteno-
sis, small caliber rectum, and bulky mesentery or specimen.
Concerns related to transanal extraction include intraab-
dominal contamination leading to pelvic sepsis and poor on-
cologic outcomes. A recent series of 21 patients had no epi-
sodes of pelvic sepsis [15]. Transvaginal specimen extraction
has proven safe in small series without adverse events [12,
14]; however, this technique excludes women of childbearing
age for risk of infertility and women with severe pelvic adhe-
sions.Furtherevaluationneedstooccurregardinglong-term
dyspareunia from this approach. No randomized data exists
studying the long-term oncologic outcomes, including site
of tumor recurrence, for natural oriﬁce specimen extraction
for colorectal malignancy; however, extracting the specimen
viaaspecimenretrievalbagsystemtopreventcontamination
of the tract (similar to a wound protector) adheres to sound
oncologicprinciplesandpracticesalreadyinplaceforlaparo-
scopic techniques. This laparoscopic/endoscopic surgical
platform may require intracorporeal anastomosis, which
requires surgeons adept with this technique.
Entirely NOTES colectomy in a live human has yet to be
performed.Lacyetal.performedaminilaparoscopic-assisted
NOTES sigmoidectomy via a transvaginal technique for sig-
moid adenocarcinoma in 2008 [62]. Whiteford utilized ca-
daveric models to demonstrate feasibility of a radical sig-
moid colectomy using a NOTES technique with transanal
endoscopic microsurgery (TEM) technology [63]. Although
feasible,themesorectalandretroperitonealdissectiontomo-
bilize the mesorectum from the presacral space may not
clearly identify and preserve nerves in this area as the dis-
section begins inferiorly at the sacrum and works superiorly
toward the proximal margin. This will require further in-
vestigation if this technique is to be performed in humans.
Moreover, the paper describes a blind coupling of the stapler
and anvil of an EEA stapler and blind stapler ﬁring. Con-
cerns for this technique include no visualization during
the anastomosis and potential twisting or tension on the
anastomosis. A handsewn technique utilizing standard TEM
principles may obviate these concerns. Two studies in animal
models demonstrated NOTES sigmoidectomy via an oper-
ating gastroscope [64, 65]. A novel tool for retraction of the
sigmoidcolonwasutilized,thatis,apairedmagnettechnique
that incorporates a magnet on the end of a sigmoidoscope
and an external magnet. These paired magnets, therefore,
allow retraction and movement of the sigmoid colon to
facilitate dissection. Further, novel closure devices including
endoscopic tacks have been used to close enterotomy defects
[66].
As these tools and others on the horizon approach
clinical use, more devices will be at the surgeon’s disposal.6 International Journal of Surgical Oncology
The transition to innovative techniques should occur with
caution, however. We must prove that there is patient beneﬁt
without increasing morbidity. The transition must be safe.
Appropriate education should occur for surgeons learning
new and dramatically diﬀerent techniques.
6. Conclusions
Minimally invasive surgery for colorectal cancer has been
subjected to rigorous scientiﬁc evaluation, and due to pos-
itive outcomes when done by experienced surgeons, this
approach has become the standard worldwide. Level 1 data
now supports general feasibility, safety, improved patient-
related beneﬁts and oncologic equivalence when compared
to open surgery for colon cancer. Though MIS for rectal
cancer has been extensively studied in an uncontrolled fash-
ion, multicenter randomized trials are needed to determine
oncologic equivalence to open surgery. Innovative ap-
proaches to further decrease abdominal wall trauma are cur-
rently being tested, and modiﬁcation to current approaches
will likely take place in the near future. The steep learning
curve, cost and formalized training continue to be barriers to
the widespread application of MIS techniques for colorectal
cancer. General and colorectal surgeons must remain fully
engaged in the development and application of new tech-
nologies and procedures so that surgeons can lead the way
into the future while maintaining the patient’s interests ﬁrst.
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